We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Sandbox 1666
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | ==Your Heading Here (maybe something like 'Structure')== | |
| + | <StructureSection load='3rec' size='350' side='right' caption='Escherichia coli reca protein-bound DNA (PDB entry [[3rec]])' scene=''> | ||
==CTX-M Beta-Lactamase== | ==CTX-M Beta-Lactamase== | ||
| Line 25: | Line 26: | ||
== Other Important Features == | == Other Important Features == | ||
There have been several inhibitor-resistant variants that mutations have risen from. More specifically one of them being K23YR. This mutation causes a 1500-fold decrease in the cefotaxime and a 5-fold increase in the Kcat for ampicillin. This makes it become a good penicillinase, but a poor cephalosporinase due to slow acylation. The mutation of this will lead to the enzyme being inactivated, making the drug resistance not work efficiently. | There have been several inhibitor-resistant variants that mutations have risen from. More specifically one of them being K23YR. This mutation causes a 1500-fold decrease in the cefotaxime and a 5-fold increase in the Kcat for ampicillin. This makes it become a good penicillinase, but a poor cephalosporinase due to slow acylation. The mutation of this will lead to the enzyme being inactivated, making the drug resistance not work efficiently. | ||
| - | </StructureSection> | + | </StructureSection> |
| + | |||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 19:07, 18 April 2021
Your Heading Here (maybe something like 'Structure')
| |||||||||||
